×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MRNA – moderna, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MRNA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/23
11:20 am
mrna
U.S. Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Market Research: Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030 [Yahoo! Finance]
Low
Report
U.S. Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Market Research: Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030 [Yahoo! Finance]
12/23
09:17 am
mrna
Moderna Stock Down 39% in Three Months: Buy the Dip or Wait? [Yahoo! Finance]
Low
Report
Moderna Stock Down 39% in Three Months: Buy the Dip or Wait? [Yahoo! Finance]
12/18
08:09 am
mrna
Moderna, Inc. (NASDAQ: MRNA) was downgraded by analysts at Argus from a "buy" rating to a "hold" rating.
Medium
Report
Moderna, Inc. (NASDAQ: MRNA) was downgraded by analysts at Argus from a "buy" rating to a "hold" rating.
12/10
08:00 am
mrna
Moderna, Inc. (NASDAQ: MRNA) had its "underperform" rating re-affirmed by analysts at Bank of America Co.. They now have a $41.00 price target on the stock.
Medium
Report
Moderna, Inc. (NASDAQ: MRNA) had its "underperform" rating re-affirmed by analysts at Bank of America Co.. They now have a $41.00 price target on the stock.
11/26
09:43 am
mrna
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at JPMorgan Chase & Co. from $59.00 to $45.00. They now have an "underweight" rating on the stock.
Low
Report
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at JPMorgan Chase & Co. from $59.00 to $45.00. They now have an "underweight" rating on the stock.
11/26
07:22 am
mrna
Moderna, Inc. (MRNA): An Oversold Healthcare Stock to Invest In Now [Yahoo! Finance]
Medium
Report
Moderna, Inc. (MRNA): An Oversold Healthcare Stock to Invest In Now [Yahoo! Finance]
11/25
07:00 am
mrna
Moderna to Present at Upcoming Conferences in December 2024
Medium
Report
Moderna to Present at Upcoming Conferences in December 2024
11/22
10:23 am
mrna
Moderna, Inc. (MRNA) Jefferies London Healthcare Conference (Transcript) [Seeking Alpha]
Low
Report
Moderna, Inc. (MRNA) Jefferies London Healthcare Conference (Transcript) [Seeking Alpha]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/10
04:08 pm
mrna
Form 4 Moderna, Inc. For: Dec 06 Filed by: Klinger Shannon Thyme
Medium
Report
Form 4 Moderna, Inc. For: Dec 06 Filed by: Klinger Shannon Thyme
12/9
03:19 pm
mrna
Form 144 Moderna, Inc. Filed by: Klinger Shannon Thyme
Low
Report
Form 144 Moderna, Inc. Filed by: Klinger Shannon Thyme
12/6
04:55 pm
mrna
Form 4 Moderna, Inc. For: Dec 05 Filed by: Mock James M
Low
Report
Form 4 Moderna, Inc. For: Dec 05 Filed by: Mock James M
12/6
04:51 pm
mrna
Form 4 Moderna, Inc. For: Dec 05 Filed by: Klinger Shannon Thyme
Low
Report
Form 4 Moderna, Inc. For: Dec 05 Filed by: Klinger Shannon Thyme
12/4
05:12 pm
mrna
Form 4 Moderna, Inc. For: Dec 02 Filed by: Klinger Shannon Thyme
Low
Report
Form 4 Moderna, Inc. For: Dec 02 Filed by: Klinger Shannon Thyme
12/4
05:08 pm
mrna
Form 4 Moderna, Inc. For: Dec 02 Filed by: Hoge Stephen
Low
Report
Form 4 Moderna, Inc. For: Dec 02 Filed by: Hoge Stephen
12/3
04:11 pm
mrna
Form 144 Moderna, Inc. Filed by: Klinger Shannon Thyme
Low
Report
Form 144 Moderna, Inc. Filed by: Klinger Shannon Thyme
12/3
03:24 pm
mrna
Form 144 Moderna, Inc. Filed by: Hoge Stephen
Low
Report
Form 144 Moderna, Inc. Filed by: Hoge Stephen
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
Germany's CureVac says low-dose coronavirus vaccine could allow for mass production [Yahoo! Finance News]
28.0%
2/24 Form 4 Moderna, Inc. For: Feb 20 Filed by: Bancel Stephane 27.8%
4/16 Moderna Announces Award from U.S. Government Agency BARDA for up to $483 Million to Accelerate Development of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus 21.3%
2/25 Form 4 Moderna, Inc. For: Feb 24 Filed by: Hoge Stephen 19.8%
3/17 Form 4 Moderna, Inc. For: Mar 13 Filed by: Bancel Stephane 16.7%
2/28 A Big Coronavirus Mystery: Where Are The Children? [zero hedge] 14.4%
4/19 4 Top Stock Trades for Monday: BA, MRNA, SLB, KSU [Yahoo! Finance News] 12.6%
4/1 White House advisor Fauci says coronavirus vaccine trial is on target and will be 'ultimate game changer' [CNBC] 12.2%
4/15 Coronavirus updates: Trump says states will decide when to reopen [CBS News] 9.2%
3/25 Moderna to Present at MIT Lecture Series 9.2%
2/24 Form 4 Moderna, Inc. For: Feb 20 Filed by: Bancel Stephane 27.8%
4/16 Moderna Announces Award from U.S. Government Agency BARDA for up to $483 Million to Accelerate Development of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus 21.3%
2/25 Form 4 Moderna, Inc. For: Feb 24 Filed by: Hoge Stephen 19.8%
3/17 Form 4 Moderna, Inc. For: Mar 13 Filed by: Bancel Stephane 16.7%
2/28 A Big Coronavirus Mystery: Where Are The Children? [zero hedge] 14.4%
4/19 4 Top Stock Trades for Monday: BA, MRNA, SLB, KSU [Yahoo! Finance News] 12.6%
4/1 White House advisor Fauci says coronavirus vaccine trial is on target and will be 'ultimate game changer' [CNBC] 12.2%
4/15 Coronavirus updates: Trump says states will decide when to reopen [CBS News] 9.2%
3/25 Moderna to Present at MIT Lecture Series 9.2%
TOP News Decliners
2/26
Trump says U.S. ‘very ready’ for coronavirus; Mike Pence to lead response [Toronto Globe and Mail (Ontario, Canada)]
-20.7%
3/6 Form 4 Moderna, Inc. For: Mar 04 Filed by: Kim Lorence H. -17.9%
3/19 Here are 3 drugs in development to fight coronavirus, 2 vaccines and one 'passive' vaccine [DailyFinance (AOL.com)] -14.3%
1/9 Moderna +16% on positive CMV vaccine data [Seeking Alpha] -13.0%
3/10 7 Stocks Poised to Profit From Coronavirus [Yahoo! Finance News] -11.5%
2/11 Form SC 13G Moderna, Inc. Filed by: VANGUARD GROUP INC -10.8%
5/7 Form 8-K Moderna, Inc. For: May 07 -9.4%
3/23 Form 8-K Moderna, Inc. For: Mar 23 -8.9%
4/27 Moderna submits IND application for Phase 2 COVID-19 study [Seeking Alpha] -8.5%
1/28 US health officials fast-track coronavirus vaccine, hope to start clinical trial in three months [MSNBC.com] -8.1%
3/6 Form 4 Moderna, Inc. For: Mar 04 Filed by: Kim Lorence H. -17.9%
3/19 Here are 3 drugs in development to fight coronavirus, 2 vaccines and one 'passive' vaccine [DailyFinance (AOL.com)] -14.3%
1/9 Moderna +16% on positive CMV vaccine data [Seeking Alpha] -13.0%
3/10 7 Stocks Poised to Profit From Coronavirus [Yahoo! Finance News] -11.5%
2/11 Form SC 13G Moderna, Inc. Filed by: VANGUARD GROUP INC -10.8%
5/7 Form 8-K Moderna, Inc. For: May 07 -9.4%
3/23 Form 8-K Moderna, Inc. For: Mar 23 -8.9%
4/27 Moderna submits IND application for Phase 2 COVID-19 study [Seeking Alpha] -8.5%
1/28 US health officials fast-track coronavirus vaccine, hope to start clinical trial in three months [MSNBC.com] -8.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: